Cargando…

Modelling Circulating Tumour Cells for Personalised Survival Prediction in Metastatic Breast Cancer

Ductal carcinoma is one of the most common cancers among women, and the main cause of death is the formation of metastases. The development of metastases is caused by cancer cells that migrate from the primary tumour site (the mammary duct) through the blood vessels and extravasating they initiate m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ascolani, Gianluca, Occhipinti, Annalisa, Liò, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433130/ https://www.ncbi.nlm.nih.gov/pubmed/25978366 http://dx.doi.org/10.1371/journal.pcbi.1004199

Ejemplares similares

Modeling breast cancer progression to bone: how driver mutation order and metabolism matter
por: Ascolani, Gianluca, et al.
Publicado: (2019)

Modeling TGF-β in Early Stages of Cancer Tissue Dynamics
por: Ascolani, Gianluca, et al.
Publicado: (2014)

Combining Pathway Identification and Breast Cancer Survival Prediction via Screening-Network Methods
por: Iuliano, Antonella, et al.
Publicado: (2018)

Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients
por: Muendlein, Axel, et al.
Publicado: (2021)

Landscape of circulating tumour DNA in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2020)

PECLIDES Neuro: A Personalisable Clinical Decision Support System for Neurological Diseases
por: Müller, Tamara T., et al.
Publicado: (2020)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
por: Weigelt, B, et al.
Publicado: (2003)

Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything
por: Capici, Serena, et al.
Publicado: (2022)

Cancer Markers Selection Using Network-Based Cox Regression: A Methodological and Computational Practice
por: Iuliano, Antonella, et al.
Publicado: (2016)

Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer
por: Lee, Chun-Hui, et al.
Publicado: (2019)

Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients
por: Payne, R E, et al.
Publicado: (2012)

CiliateGEM: an open-project and a tool for predictions of ciliate metabolic variations and experimental condition design
por: Mancini, Alessio, et al.
Publicado: (2018)

Machine learning application in personalised lung cancer recurrence and survivability prediction
por: Yang, Yang, et al.
Publicado: (2022)

Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
por: Kirwan, C. C., et al.
Publicado: (2019)

Personalised mapping of tumour development in synchronous colorectal cancer patients
por: Thomas, Valentina, et al.
Publicado: (2020)

Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer
por: Peeters, D J E, et al.
Publicado: (2011)

Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
por: Krawczyk, Natalia, et al.
Publicado: (2019)

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2022)

Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity
por: Fisher, Rosalie, et al.
Publicado: (2011)

Predicting factors for survival of breast cancer patients using machine learning techniques
por: Ganggayah, Mogana Darshini, et al.
Publicado: (2019)

Image Analysis of Circulating Tumor Cells and Leukocytes Predicts Survival and Metastatic Pattern in Breast Cancer Patients
por: Da Col, Giacomo, et al.
Publicado: (2022)

Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer
por: Ryoo, Seung-Bum, et al.
Publicado: (2023)

Imaging Biomarkers of Tumour Proliferation and Invasion for Personalised Lung Cancer Therapy
por: Marcu, Loredana G.
Publicado: (2020)

Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
por: Vera-Ramirez, Laura, et al.
Publicado: (2018)

Circulating tumour cells in breast cancer
por: Krawczyk, Natalia, et al.
Publicado: (2013)

A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer
por: Chou, Wen-Chi, et al.
Publicado: (2018)

Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients
por: Mego, M, et al.
Publicado: (2009)

Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer
por: Gardner, Kirby P., et al.
Publicado: (2022)

A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer
por: Varkaris, Andreas, et al.
Publicado: (2019)

Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
por: Murtaza, Muhammed, et al.
Publicado: (2015)

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2011)

Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes
por: Peeters, D J E, et al.
Publicado: (2014)

Circulating tumour DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer
por: Abbosh, C, et al.
Publicado: (2018)

Circulating tumour cells predict survival in gastric cancer patients: a meta-analysis
por: Wang, Hui-Yu, et al.
Publicado: (2016)

BST-2 promotes survival in circulation and pulmonary metastatic seeding of breast cancer cells
por: Mahauad-Fernandez, Wadie D., et al.
Publicado: (2018)

The Mediterranean Diet and Breast Cancer: A Personalised Approach
por: Shaikh, Amani Al, et al.
Publicado: (2019)

Nomogram for the personalisation of radiotherapy treatments in breast cancer patients
por: Beato Tortajada, Inmaculada, et al.
Publicado: (2021)

Breast density measurement for personalised screening
por: Sergeant, JC, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jvobpmhc04rpgahkqa63i39n20